Buy Pramipexole dihydrochloride .25 mg/1 Pramipexole dihydrochloride

Pramipexole dihydrochloride .25 mg tablets are used for managing symptoms of Parkinson's disease and restless legs syndrome. This oral medication is available in a 30-tablet blister pack.

Strength

.25 mg/1

Pack Size

30 TABLET in 1 BLISTER PACK (0615-8551-39)

Manufacturer / TM Owner

NCS HealthCare of KY, LLC dba Vangard Labs

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Pramipexole dihydrochloride is primarily used to treat symptoms associated with Parkinson's disease, such as tremors, stiffness, and difficulty moving. It is also prescribed for restless legs syndrome, helping to alleviate discomfort and involuntary leg movements. The medication works by affecting the dopamine levels in the brain, which can improve motor function and reduce symptoms.

Side Effects

Common effects of Pramipexole dihydrochloride may include dizziness, nausea, and fatigue. Some users might experience sleepiness or hallucinations, particularly at higher doses. It is important to monitor for any unusual side effects and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Pramipexole dihydrochloride should be handled with care, especially for individuals with a history of mental health conditions or heart problems. It is essential to follow the prescribed dosage and avoid sudden discontinuation. Pregnant or breastfeeding women should consult a healthcare provider before use.

Avoid Interactions

Pramipexole dihydrochloride may interact with alcohol, increasing the risk of dizziness and drowsiness. It can also interact with certain medications that affect dopamine levels or are metabolized by the liver. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

Pramipexole dihydrochloride is used to manage symptoms of Parkinson's disease and restless legs syndrome.

Pramipexole dihydrochloride is taken orally, typically as directed by a healthcare provider.

Common side effects include dizziness, nausea, fatigue, and sleepiness.

It is advisable to avoid alcohol while taking Pramipexole dihydrochloride, as it may increase dizziness and drowsiness.

Pregnant women should consult a healthcare provider before using Pramipexole dihydrochloride.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.